We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OFLX icon
3226
Omega Flex
OFLX
$284M
$18K ﹤0.01%
195
-264
-58% -$25K
PHI icon
3227
PLDT
PHI
$4.19B
$18K ﹤0.01%
+773
New +$20.4K
PIPR icon
3228
Piper Sandler
PIPR
$5.45B
$18K ﹤0.01%
552
-4,548
-89% -$149K
RDIB
3229
Reading International Class B
RDIB
$18K ﹤0.01%
913
-3,049
-77% -$60.2K
RDNW
3230
RideNow Group
RDNW
$248M
$18K ﹤0.01%
2,762
+1,031
+60% +$11.2K
ROIV icon
3231
Roivant Sciences
ROIV
$26.2B
$18K ﹤0.01%
2,322
-3,054
-57% -$17K
RXRX icon
3232
Recursion Pharmaceuticals
RXRX
$1.7B
$18K ﹤0.01%
2,299
-13,112
-85% -$129K
SM icon
3233
SM Energy
SM
$8.05B
$18K ﹤0.01%
532
-9,159
-95% -$381K
SMLR
3234
DELISTED
Semler Scientific
SMLR
$18K ﹤0.01%
531
+433
+442% +$15K
SSTI icon
3235
SoundThinking
SSTI
$82.8M
$18K ﹤0.01%
548
-77
-12% -$2.57K
THRM icon
3236
Gentherm
THRM
$1.35B
$18K ﹤0.01%
289
-4,855
-94% -$314K
UEVM icon
3237
VictoryShares Emerging Markets Value Momentum ETF
UEVM
$250M
$18K ﹤0.01%
+459
New +$17.5K
VINP icon
3238
Vinci Compass Investments Ltd
VINP
$626M
$18K ﹤0.01%
1,951
-453
-19% -$4.51K
VRA icon
3239
Vera Bradley
VRA
$93.6M
$18K ﹤0.01%
+4,058
New +$14.8K
VRCA icon
3240
Verrica Pharmaceuticals
VRCA
$85.9M
$18K ﹤0.01%
636
-69
-10% -$1.84K
VRNS icon
3241
Varonis Systems
VRNS
$5.15B
$18K ﹤0.01%
779
-19,905
-96% -$455K
LOGC
3242
DELISTED
ContextLogic
LOGC
$18K ﹤0.01%
1,234
-1,954
-61% -$40.2K
ONIT
3243
Onity Group
ONIT
$326M
$18K ﹤0.01%
586
+197
+51% +$6.15K
IRD
3244
Opus Genetics
IRD
$300M
$18K ﹤0.01%
5,103
+1,711
+50% +$4.5K
ATSG
3245
DELISTED
Air Transport Services Group
ATSG
$18K ﹤0.01%
694
-3,389
-83% -$93.3K
B
3246
DELISTED
Barnes Group Inc.
B
$18K ﹤0.01%
457
-8,475
-95% -$317K
DNMR
3247
DELISTED
Danimer Scientific, Inc.
DNMR
$18K ﹤0.01%
254
+83
+49% +$7.85K
SILK
3248
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$18K ﹤0.01%
333
-2,854
-90% -$139K
TRVN
3249
DELISTED
Trevena, Inc.
TRVN
$18K ﹤0.01%
496
+404
+439% +$33.6K
NXGN
3250
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$18K ﹤0.01%
959
-64,549
-99% -$1.24M

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.